The START Center for Cancer Research
Deeply rooted in community oncology centers globally, the START Center for Cancer Research ('START') provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,500 early phase clinical trials, including for 50 therapies that have gained FDA/EMA approval.
Recently Posted Jobs at The START Center for Cancer Research
The START Center for Cancer Research Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.
Typical time on-site:
None
